Data collected from individuals submitting MDMA samples to drug-checking services between 2019 and 2022 appear to support these findings from the EWSD. For example, 79 % of the Polish respondents reported mostly buying the drug, compared to 51 % of the respondents from Luxembourg. Data from drug-checking services can also inform on the type of relationships that exist between the consumer and the provider. Web-based surveys, such as the EWSD, can provide a helpful insight, although the results cannot be generalised to the population as a whole, or indeed to all people who use drugs. For example, alcoholic drinks containing MDMA are submitted for drug checking from time to time. Samples submitted to drug-checking services buy mdma can also provide an indication of the products available to consumers.
Ecstasy adulteration is responsive to market pressures
While a slight decrease in price was observed in 2022 for ecstasy tablets, this may not be statistically significant or sustained in the coming years. In fact, it could be argued that MDMA in the form of ecstasy tablets became cheaper between 2012 and 2019 as tablets containing larger quantities of MDMA became increasingly available on the market (see Section The trend of large tablets containing more MDMA may be reversing). For countries reporting data in 2022, a considerable retail price range was observed, with prices per ecstasy tablet ranging from EUR 4 to EUR 19 (mean) and prices of MDMA powder from EUR 6 to EUR 50 per gram. Occasionally, tablets containing 250 milligrams or more of MDMA are encountered on EU drug markets. This trend may be a combination of the scheduling of PMK glycidate, and a reduction in demand for MDMA during the COVID-19 pandemic, and is in line with the changes observed in the adulteration of ecstasy tablets (see Section Ecstasy adulteration is responsive to market pressures). This means that the ratio of MDMA to fillers (excipients) in the mixtures used to make ecstasy tablets did not increase over this time period.
The data used to generate the infographics and charts on this page may be found below (CSV format). In 2022, a total of 853 clients entered drug treatment for the first time due to MDMA-related problems in 2022. At EU and country level, people seeking drug treatment for MDMA-related problems represent a very small proportion of all clients entering drug treatment – typically less than 0.5 % of all new entrants into drug treatment in any given year.
Most MDMA-related hospital emergency cases involved males, confirming trends in prevalence and patterns of use. Half of the centres reported no MDMA-related admissions to the intensive care unit. Türkiye is an outlier, with MDMA identified in almost 1 in 5 drug-induced deaths (46 out of 246 in 2022). A minority of these fatalities (13-25 %) were due to MDMA toxicity alone, with multiple drug toxicity being more prevalen
Surrey Young People’s Substance Use Service
City-level market size estimates were developed for Brussels, in Belgium, and five cities in Sweden (see Table 6.1. Estimated value of MDMA consumed in selected European cities, 2020). The price data used was the average retail price for MDMA in the country concerned, drawn from the EUDA’s annual data collection (see Section Price and purity). For some countries (Belgium, Croatia, Denmark, France, Malta, Netherlands, Norway and Türkiye) no data were available from the EWSD. The annual amounts used, in tablets, could be estimated for each survey participant based on their responses to questions on the number of tablets used on a typical day, multiplied by the number of days they said they used the drug in a year. As such, only last year prevalence and last month
buy mdma prevalence data are required to distinguish these two groups. Prevalence rates of the number of MDMA users, obtained from general population surveys, are multiplied by 2021 Eurostat population data of the age group.
A study conducted by 10 drug-checking organisations from the TEDI network found that the increase in MDMA content in tablets in this time period was directly related to an increase in the average weight of ecstasy tablets (Vrolijk et al., 2022). The average content of MDMA in ecstasy tablets appears to be on a slight downward trend from 2019, after close to a decade of increasingly stronger (and larger) tablets becoming available on the market. On occasion, neurotoxic compounds such as PMMA (5) are detected mixed with, or as a replacement for, MDMA in ecstasy tablets. From 2019 onwards a new cycle appears to have begun, whereby the number of ecstasy tablets containing other substances alongside, or instead of, MDMA has increased (as expressed by a drop in percentage in the indexed trends shown above from 96 % in 2019 to 73 % in 2022). Crystal MDMA was marketed as a purer product compared to ecstasy tablets, an assertion that was and remains largely true (see Section The trend of large tablets containing more MDMA may be reversing). One way to observe these cycles is to monitor rates of adulteration, as expressed by the percentage of tested samples of seized ecstasy tablets that contain MDMA and no other buy mdma scheduled substances.
Wastewater-based methods
This organization verifies Internet drugstores throughout the United States and most Canadian provinces. You may also report suspected drug activity or abuse online. (2) Data reported to the Trans-European Drug Information project (TEDI) by drug-checking services in Austria, Belgium, France, Italy, Luxembourg, Portugal, Slovenia and Spain. This may not reflect use patterns, but rather differences in the offer, legal requirement and access to drug treatment between countries.
Increased ener
